Reactivation of latent HIV moves shock-and-kill treatments forward.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Cell heterogeneity contributes to the variable response of HIV-1 to latency-reversing agents.Science advances · 2026
   Article
2. Effects of inactivated COVID-19 vaccination on HIV viremia and reservoir size: a longitudinal cohort study.BMC infectious diseases · 2025
   Observational
3. Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.Frontiers in immunology · 2024
   Review
4. HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo.Cells · 2022
   Article
5. Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity.Biomolecules · 2022
   Review
6. Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment.Pharmaceuticals (Basel, Switzerland) · 2022
   Article
7. EK-16A liposomes enhance HIV replication in ACH2 or J-Lat 10.6 cell engrafted NSG mice.Nanotheranostics · 2022
   Article
8. Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection.Viruses · 2021
   Review
9. Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.PLoS pathogens · 2021
   Article
10. Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections.Viruses · 2021
    Review
11. Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors.Communications biology · 2021
    Article
12. Nanotechnology for virus treatment.Nano today · 2021
    Review

Corrections and comments

• Comment on
  Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD82020
• Comment on
  Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo.2020

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as